Influenza mRNA Vaccine Clinical Trials

Home | Studies | Influenza mRNA Vaccine Clinical Trials

Be a Part of the Next Flu Vaccine Breakthrough

Participate in Influenza mRNA Vaccine Clinical Trials!

Today’s flu vaccines undergo updates every year to prevent infection with the specific strains of the flu that scientists expect to be common that year. It takes several months to develop vaccines that are effective against the strain of virus that may be circulating.

However recent advances in mRNA technology are proving to be helpful to scientists and researchers. This helps them develop new vaccines that take less time to produce and maybe a better match to most common flu strains. Revival Research Institute is conducting Influenza mRNA Vaccine Clinical Trials to study the safety and efficacy of this investigational product that could potentially help the body produce antibodies that might fight off the flu.

You may be eligible for the Influenza mRNA Vaccine Clinical Trials if you:

Are at least 65 years of age
Have stable chronic conditions or are healthy
Have not received an investigational or licensed flu vaccine in the last 6 months
Additional criteria may apply

We are conducting a Phase 3 mRNA Flu Vaccine Study. This could be the breakthrough we need to fight against flu and other infectious diseases.

*To participate in the Influenza mRNA Vaccine Clinical Trials, please fill out the form, and someone from our research team will give you a call.
**The study vaccine and study-related care will be provided at no cost. If you decide to participate, there is no requirement for insurance.

*Who is this information for?

A Family Member

A Friend

My Patient

Please provide YOUR contact information only.

First Name

Last Name

Phone

Confirm Phone

Best time to call?

Morning

Middle of the day

Evening

State

How did you hear about us?*

Comments

User Agreement*

By Signing up, I agree to be contacted via calls and SMS.

About Influenza mRNA Vaccine Clinical Trials

Revival Research Institute is conducting a Phase 3 Influenza mRNA Vaccine Clinical Trial that may last up to 6 months. This study will help us learn if the investigational vaccine is safe and effective to use. The goal of the influenza Clinical Trial is to observe whether the mRNA study vaccine can help one develop antibodies that may help fight the flu.

The investigational vaccine may help your body develop antibodies by activating your immune system using mRNA. There is no weakened or dead flu virus in the investigational product. Participation in the Influenza mRNA Vaccine Clinical Trials could be a potential breakthrough in our fight against flu and other infectious diseases. If you are eligible to participate in the Clinical Trial and decide to take part, you will be assigned to one of two groups where you might receive the study vaccine or a licensed flu shots in Michigan, approved by health authorities.

*Participating in the Influenza mRNA Vaccine Clinical Trials is completely voluntary. You can discontinue or stop taking part at any time.
**There will be other study requirements the study team will discuss with you if you participate in this study.

Get Started: What to Expect?

If you meet the study criteria, you will be randomly assigned to one of two groups. One of the groups will receive the investigational mRNA flu vaccine. The other group will receive the licensed flu shots in Michigan that has be approved by the appropriate health authorities. Every participant will have an equal chance of receiving the investigational vaccine or the licensed flu shot. Neither you nor your study doctor and certain members of the research team will know which flu vaccine you receive.

After you fill out the form above, someone from our research will give you a call. If you fit the study’s eligibility criteria, someone from our research team will invite you to the study site’s location (within a 50-mile radius). Before you decide to participate, our study team will brief you on all details about participating in the Clinical Trial, including the risks and benefits. Throughout the study, the research team will monitor for symptoms of flu. If you develop any flu-like symptoms, there may be an additional visit to the site for a health check.

Condition

Influenza (Flu) Vaccine

Length of Study Treatment

6 months

Number of Study Visits

Approx. 3 visits

About mRNA Vaccines

Understanding Traditional Vaccines & How They Work

Vaccines aid the body’s natural defenses against diseases brought on by bacteria, viruses, or other pathogens. Many vaccines today contain the dead or weakened part of the pathogen (be it the virus, or bacteria from the disease they intend to target). This is then introduced into the body which generates the body’s immune system’s response. Vaccines simply provide a boost to the already present body’s natural defense mechanism (immune system). Since parts of the vaccines that contain the pathogen are dead or weakened, they cannot make a person sick. Vaccines help the immune system recognize pathogens like viruses and bacteria that may invade the body.

Understanding mRNA Vaccines

mRNA vaccines operate a bit differently compared to traditional vaccines. They do not contain the dead or weakened part of the pathogen but instead, they stimulate the production of proteins in your body exactly the way how a real pathogen would. These proteins cause the immune system to respond similarly to a real pathogen. Therefore, specific immune system cells “remember” how to swiftly identify these proteins and combat the actual illness if it manifests itself in the future.

Frequently Asked Questions

Is the Influenza Vaccine made of mRNA technology?

In the current study, flu shots in Michigan are made from mRNA technology. The investigational vaccine is thought to work by activating your body’s natural defence mechanism, the immune system by using mRNA. There is no dead or weakened part of the virus in the study vaccine.